Main Article Content
In patients with breast cancer, neoadjuvant treatment plays a fundamental role in decreasing tumor size allowing conservative surgery without a significant increase in local recurrence. More recent studies have also revealed a significant impact of neoadjuvant treatment on eradication of axillary disease. This is the case of a 46-year-old female with invasive ductal carcinoma and with axillary disease proven histologically. After marking both lesions with radiopaque material, the patient started neoadjuvant chemotherapy followed by conservative surgery. Selective sentinel lymph node biopsy revealed the absence of neoplastic cells as well as piece of tumorectomy, both previously marked. Neoadjuvant treatment associated with previous marking lesions, allowed conservative surgery with a complete response to treatment, besides avoiding axillary dissection.
Received: 04/10/2016 - Accepted: 04/12/2017